Abstract
ObjectivesEvaluate efficacy and safety of tabalumab, a human IgG4 monoclonal antibody that binds and neutralises membrane and soluble B-cell activating factor (BAFF) versus placebo plus standard of care (SoC) in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have